Patients living in Medicaid expansion states with newly diagnosed breast, lung or colorectal cancer have a 2 percent hazard of death reduction compared to those living in states without Medicaid expansion, according to a recent study published in JAMA Network…
Oncology
November is Pancreatic Cancer Awareness Month, and amid the news of Jeopardy! host Alex Trebek's death, the lasting legacy he left on pancreatic cancer awareness and the patient community lives on.
My family has a history of breast cancer. It affected my mother, grandmother and maternal uncle. I was my mother’s primary caretaker for years before she passed away in my early twenties. This was a painful and traumatic time for…
The antidepressant drug paroxetine led to a significant reduction in childhood sarcoma tumor growth after being used to treat cancer cells in a mouse model study, according to research published Nov. 6 in Cancer Research.
A number of obstacles can stand in the way of Black women receiving timely breast cancer treatment, including lack of insurance, transportation access and financial strain, reports STAT.
Advertisement
The COVID-19 pandemic has had a profound impact on cancer screenings and treatments, and researchers are now warning that delaying cancer treatment by just one month can lead to a 6 percent to 13 percent higher death risk, according to…
Using proton therapy to treat lung cancer patients was linked to a reduction in ministrokes and heart attacks compared to patients who received traditional photon-based therapy, according to new research from Philadelphia-based Penn Medicine.
Reno, Nev.-based Renown Health debuted a new cancer center leadership team Oct. 29 with the appointment of Max Coppes, MD, PhD, as the cancer center director for Renown's Institute for Cancer, and Larry Duncan as the cancer center administrator, according…
Genetic testing identifies inherited cancer mutations more effectively than a standard guideline-based approach, according to research published in JAMA Oncology.
The U.S. Department of Defense Breast Cancer Research Program awarded Erik Nelson, PhD, the $4.5 million Era of Hope Scholar Award Oct. 30 to lead a research team that will study metastatic breast cancer treatment and prevention.